Skip to main content

Shwas-rog Series-3 Understanding the mechanism of Samprapti with 'URASTHAH KAPHAMUDDHUYA' by Prof. Satyendra Ojha

рдоाрд░ुрддः рдк्рд░рдгрд╡ाрд╣ीрдиि рд╕्рд░ोрддांрд╕ि рдЖрд╡िрд╢्рдп  рдХुрдк्рдпрддि !
рдЙрд░рд╕्рде: рдХрдлрдоुрдж्рдзूрдп рд╣िрдХ्рдХाрд╢्рд╡ाрд╕ाрдЩрдХрд░ोрддि  !!
                                                 (Ch.chi.17/17)

  Explains the hyperplasia of mucus secretion as seen in COPD wherein small airways may become narrowed by cells (hyperplasia and accumulation), mucus, and fibrosis. Characteristic cellular changes include goblet cell metaplasia, with these mucus-secreting cells replacing surfactant-secreting Clara cells. Smooth-muscle hypertrophy (kupyati maruta) may also be present. 

These abnormalities may cause luminal narrowing by fibrosis, excess mucus, edema, and cellular infiltration.
Vitiated vata expels kapha from its sthana can be easily understood in case of cystic fibrosis. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) which is an integral membrane protein that functions as an epithelial anion channel. The ~1480-amino-acid molecule encodes a passive conduit for chloride and bicarbonate transport across plasma membranes of epithelial tissues, with direction of ion flow dependent on the electrochemical driving force. 

The function resembles that of vata thus it can be said that CFTR is vatadharmi dravya. Along respiratory mucosa, CFTR is necessary to provide sufficient depth of the periciliary fluid layer (PCL), allowing normal ciliary extension and mucociliary transport (normal function of vata). But in cystic fibrosis this CFTR-deficient airway cells exhibit depleted PCL (kupita vata), causing ciliary collapse and failure to clear overlying mucus. In airway submucosal glands, CFTR is highly expressed in acini and may participate both in the formation of mucus and extrusion of glandular secretion onto the airway surface (udhuya kapham) thus obstructing, the gati of pran leading to oxygen and carbon dioxide mismatch and therefore difficulty in breathing.
In other condition this kapha (inspissated mucus) helps in further growth of bacterial infection leading to collateral tissue injury and further aggravates respiratory decline.
Sometimes inorganic and organic dust, are associated with chronic mucus hypersecretion (chronic bronchitis), with or without reduction of expiratory flow rates.
Mucus hyper secretion Increased mucus secretion contributes to the viscid mucous plugs that occlude asthmatic airways, particularly in fatal asthma. There is hyperplasia of submucosal glands that are confined to large airways and of increased numbers of epithelial goblet cells. IL-13 (kupyati maruta dharma dravya) induces mucus hypersecretion in experimental models of asthma.
Inflammatory Mediators Multiple inflammatory mediators have been implicated in asthma, and they may have a variety of effects on the airways that account for the pathologic features of asthma. Mediators such as histamine, prostaglandin D2, and cysteinyl-leukotrienes contract airway smooth muscle, increase microvascular leakage, increase airway mucus secretion (kapham udhuya), and attract other inflammatory cells. Because each mediator has many effects, the role of individual mediators in the pathophysiology of asthma is not yet clear. Although the multiplicity of mediators makes it unlikely that preventing the synthesis or action of a single mediator will have a major impact in clinical asthma, recent clinical studies with antileukotrienes suggest that cysteinyl-leukotrienes have clinically important effects. The mediators are the vata dharma dravya.

Such description can help to get more effective treatment for рддрдордХ рд╢्рд╡ाрд╕ ।


**************************************************************************************************************************


MD PhD
(Kayachikitsa)
Director,
Yashwant Ayu.College & P.G.Training&Research Center, 
Kodoli, Kolhapur, Maharashtra, India.
Mobile No.- +91 9822177155     

email: drsnojha@rediffmail.com

Comments

Popular posts from this blog

CLINICAL AYURVEDA PART-15: Case presentation- рд╡िрд╢рдж рдЧुрдг - рд╕ैрдж्рдзाрди्рддिрдХ рдПрд╡ं рдк्рд░ाрдпोрдЧिрдХ рд╕्рд╡рд░ूрдк by Vaidyaraja Subhash Sharma

[12/14, 7:09 PM] Vaidyaraj Subhash Sharma: CLINICAL AYURVEDA PART-15 *case presentation-  рд╡िрд╢рдж рдЧुрдг - рд╕ैрдж्рдзाрди्рддिрдХ рдПрд╡ं рдк्рд░ाрдпोрдЧिрдХ рд╕्рд╡рд░ूрдк рдоें ENLARGEMENT OF PROSTATE & PSA рдХे рдЙрджाрд╣рд░рдг рдХे рд╕ाрде ....* *рд╕рд░्рд╡рдк्рд░рдердо рд╡िрд╢рдж рдХी рдиिрд░ूрдХ्рддि рдПрд╡ं рдкрд░िрднाрд╖ा рджेрдЦें рддो рдкृрдердо рджृрд╖्рдЯि рдоें рд╣ी рдЗрд╕рдХा рдорд╣рдд्рд╡ рдЪिрдХिрдд्рд╕ा рдоें рдХिрддрдиा рдЕрдзिрдХ рд╣ै рдпрд╣ рд╕्рдкрд╖्рдЯ рд╣ो рдЬाрддा рд╣ै, 'рд╢рддрд▓ृ рд╢ाрддрдиे' рдзाрддु рдоें рдЯрдХ् рдк्рд░рдд्рдпрдп рд╕े рд╡िрд╕рд░्рдЧ рдкूрд░्рд╡рдХ рд╡िрд╢рдж рд╢рдм्рдж рдХी рдЙрдд्рдкрдд्рддि рд╣ोрддी рд╣ै рдЬिрд╕рдХा рдЕрднिрдк्рд░ाрдп рд╢ुрдж्рдз рдмрдиा рджेрдиा рдФрд░ рд╕ंрд╢ोрдзрди рдХрд░ рджेрдиा рд╣ै।* *рд╕ुрд╢्рд░ुрдд рдХी рд╣ेрдоाрдж्рд░ि рдЯीрдХा рдоें рдЗрд╕े 'рд╢ुрдЪि рд╡िрдорд▓ी рддु рд╡िрд╢рдж рд╡िрд╢ेрд╖ौ рдЕрджृрд╖्рдЯाрдиा рд╣ि рдорд▓ाрдиां рдХ्рд╖ाрд▓рдиे рд╢рдХ्рддिं рд╢ुрдЪिрдд्рд╡ं рджृрд╖्рдЯाрдиां рд╡िрдорд▓рдд्рд╡' рд▓िрдЦा рд╣ै рдЕрд░्рдеाрдд рдЬो рдж्рд░рд╡्рдп рд╢рд░ीрд░ рдоें рджोрд╖, рдзाрддु рдПрд╡ं рдорд▓ों рдХा рд╢ुрдж्рдзिрдХрд░рдг рдХрд░ рдХे рдЙрди्рд╣े рд╡िрдорд▓рдд्рд╡ рдЕрд░्рдеाрдд рд╢ुрдж्рдз, рдиिрд░्рдорд▓ рдПрд╡ं рдкाрд░рджрд░्рд╢ी рд╕рджृрд╢ рдмрдиा рджे рдЙрд╕े рд╡िрд╢рдж рдХрд╣ा рдЧрдпा рд╣ै।* *'рдкिрдЪ्рдЫिрд▓ो рдЬीрд╡рдиो рдмрд▓्рдпः рд╕рди्рдзाрдиः рд╢्рд▓ेрд╖्рдорд▓ो рдЧुрд░ुः, рд╡िрд╢рджो рд╡िрдкрд░ीрддोрд╜рд╕्рдоाрдд् рдХ्рд▓ेрджाрдЪूрд╖рдгрд░ोрдкрдгः'  рд╕ु рд╕ू 46/517  рдпрд╣ां рдЖрдЪाрд░्рдп рд╕ुрд╢्рд░ुрдд рдЗрд╕े рдкिрдЪ्рдЫिрд▓ рдХे рд╡िрдкрд░ीрдд рдХрд░्рдо рд╡ाрд▓ा рдЕрд░्рдеाрдд рд╢рд░ीрд░ рдоें рд╕े рдХ्рд▓ेрдж рдХा рд╢ोрд╖рдг рдХрд░ рдиिрд░्рдорд▓ рдмрдиाрддा рд╣ै рдФрд░ рд░ोрдкрдг рдХрд░्рдо рднी рдХрд░рддा рд╣ै।рдЬो рд╢рд░ीрд░ рдоें ...

Case presentation: рдпрдХृрдж्рджाрд▓्рдпुрджрд░ {Non Alcoholic Fatty Liver Disease (NAFLD)} by Vaidyaraja Subhash Sharma

*Case-presentation*  - рдпрдХृрдж्рджाрд▓्рдпुрджрд░-  Non-Alcoholic Fatty Liver Disease (NAFLD) progressing to Compensated Cirrhosis * -------------------- *Vaidyaraja Subhash Sharma, MD (kaya chikitsa, jamnagar - 1985)* --------------- *Chapter -1* *рдоाрдзрд╡ рдиिрджाрди рдХा рдХाрд▓ 1200 рд╕े 1400 рд╡рд░्рд╖ рдкूрд░्рд╡ рддрдХ рдоाрдиा рдЧрдпा рдЬिрд╕рдоें рдЙрджрд░ рд░ोрдЧों рдоें рдпрдХृрдж्рджाрд▓्рдпुрджрд░ рдХा рдЙрд▓्рд▓ेрдЦ рд▓рдХ्рд╖рдгों рд╕рд╣िрдд рд╣ै। рддрдм рддो liver fibroscan рдХी рд╕ुрд╡िрдзा рдирд╣ीं рдеी।рдХिрд╕ рдк्рд░рдХाрд░ рд╕े рдЖрдЪाрд░्рдп рдЗрд╕ рдк्рд░рдХाрд░ рдХी рдЧंрднीрд░ рд╡्рдпाрдзिрдпों рдХी рдкрд░ीрдХ्рд╖ा рдХрд░ рд╕рдЯीрдХ рдиिрджाрди рдПрд╡ं рдЪिрдХिрдд्рд╕ा рдХрд░рддे рдеे ! рдЖрдЬ рд╕्рдкрд╖्рдЯ рдХрд░ेंрдЧे рдЪिрдХिрдд्рд╕ोрдкрдпोрдЧी рд╢ाрд╕्рдд्рд░ों рдоें рдЗрд╕ рд░ोрдЧ рдкрд░ рд╡рд░्рдгिрдд рд╕ूрдд्рд░ों рдХी clinical applications...* *1- рдЬ्рдЮाрдиेрди्рдж्рд░िрдпों рдПрд╡ं рдХрд░्рдоेрди्рдж्рд░िрдпों рдХो рд╕рдорд░्рде рдПрд╡ं рд╕рдХ्рд╖рдо рдмрдиाрдХрд░ рдиिрджाрди рдоें рдЙрдкрдпोрдЧ।* *2- рдпрдХृрдж्рджाрд▓्рдпुрджрд░ рдХी рдд्рд░िрд╡िрдз рдкрд░ीрдХ्рд╖ा* *3- a- рджрд╢рд╡िрдз рдкрд░ीрдХ्рд╖ा*      *b- рдд्рд░िрд╡िрдз рдк्рд░рдоाрдг рдФрд░ рдпुрдХ्рддि* *4- рдЬैрд╕े рд╕рднी рдж्рд░рд╡्рдп рдкंрдЪрднौрддिрдХ рд╣ैं рддो рд░ोрдЧ рднी рдкंрдЪрднौрддिрдХ рд╣ै, рдЗрд╕рдХी рдкंрдЪрднौрддिрдХрддा।* *5- рд░ोрдЧी рдХे рдиा рдмрддाрдиे рдкрд░ рднी рдЪिрди्рд╣ों рдж्рд╡ाрд░ा рдЗрд╕рдХा рдпा рдЕрди्рдп рд░ोрдЧों рдХा рднी рдиिрд░्рдгрдп рдХрд░рдиा।* *6- рдпрдХृрдж्рджाрд▓्рдпुрджрд░ рдХे рджोрд╖-рджूрд╖्рдп-рд╕्рд░ोрддрд╕-рд╕्рд░ोрддोрджुрд╖्рдЯि-рдЕрдЧ्...

WDS 68: Pandu and use of Gomutra (Cow's Urine) by Prof. Ramakant Sharma 'Chulet', Dr. D. C. Katoch, Vaidya Raghuram Bhatta, Dr. Pawan Madaan, Prof. Mamata Bhagwat, Dr. Ravikant Prajapati, Vd. Rangaprasad Bhat, Vd. Pratibha Navani, Dr. Kapil Kapoor, Dr. Ashwini Kumar Sood, Prof. D. N. Pandey & others.

[4/11, 20:00] Vd Saraswati Sharma:  Pranaams to all the learned vaidyas !  Request you all to kindly clarify a doubt.  How gomutra helps in pandu ?  In what type of pandu and in what stage of pandu....? If we correlate with allopathy what types of anaemia respond to gomutra and in what dosage.  What is the mode of action of gomutra wrt pandu ? [4/11, 20:54] Vd Saraswati Sharma:  Not just this, there are many pandu yogas where gomutra is one of the ingredients or used for bhavana or as sahapana. My doubt is about it's mode of action and stage of the disease where gomutra has to be advised. [4/11, 20:55] Vd Saraswati Sharma:  Gomutra is commonly used in sotha. So should we prefer it when anaemia has advanced to oedema stage or earlier too ? [4/11, 20:58] Vd Saraswati Sharma:  Gomutra alone is being advised now a days for various reasons. So if we want to let our patients who already are consuming gomutra,  ...